• Interaction Score: 5.98

    Interaction Types & Directionality:
    ligand
    antibody (inhibitory)

    Interaction Info:
    Notes EP-CAM/CD3 Bispecific antibody construct (BITE)
    Trial Name catumaxomab,Removab
    Novel drug target Novel Target

    PMIDs:
    20347527


  • Interaction Score: 4.78

    Interaction Types & Directionality:
    agonist (activating)
    antibody (inhibitory)

    Interaction Info:
    Trial Name catumaxomab,Removab
    Novel drug target Established target
    Specific Action of the Ligand Binding

  • Interaction Score: 2.28

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name catumaxomab,Removab
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • Interaction Score: 1.23

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Novel drug target Established target
    Trial Name catumaxomab,Removab

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antineoplastic agent
    Drug Class antibody
    FDA Approval not approved

    Publications:

    • Version: 12-May-2016

    Alternate Names:
    CATUMAXOMAB Drug Generic Name
    CATUMAXOMAB Primary Drug Name
    REMOVAB Drug Trade Name

    Drug Info:

    Publications:

    • Version: 29-September-2020

    Alternate Names:
    CATUMAXOMAB GuideToPharmacology Ligand Name

    Drug Info:

    Publications:

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications: